CSNK2B
Casein kinase II subunit beta
Also known as: Ckb1, Ckb2, CSK2B_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P67870
- Gene
- CSNK2B
- Ensembl
- ENSG00000204435
- Chromosome
- 6
- Canonical length
- 215 aa
- Protein class
- Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli fibrillar center,Perinuclear theca,Calyx,Mid piece
OverviewNCBI Gene
This gene encodes the beta subunit of casein kinase II, a ubiquitous protein kinase which regulates metabolic pathways, signal transduction, transcription, translation, and replication. The enzyme is composed of three subunits, alpha, alpha prime and beta, which form a tetrameric holoenzyme. The alpha and alpha prime subunits are catalytic, while the beta subunit serves regulatory functions. The enzyme localizes to the endoplasmic reticulum and the Golgi apparatus. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2013]
Canonical amino-acid sequenceUniProt
215 residues, UniProt reviewed canonical sequence.
>P67870|CSNK2B
1 MSSSEEVSWI SWFCGLRGNE FFCEVDEDYI QDKFNLTGLN EQVPHYRQAL DMILDLEPDE
61 ELEDNPNQSD LIEQAAEMLY GLIHARYILT NRGIAQMLEK YQQGDFGYCP RVYCENQPML
121 PIGLSDIPGE AMVKLYCPKC MDVYTPKSSR HHHTDGAYFG TGFPHMLFMV HPEYRPKRPA
181 NQFVPRLYGF KIHPMAYQLQ LQAASNFKSP VKTIRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CSNK2B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 288 nTPM
Expression across tissuesHPA
Tissue
- skin: 288 nTPM
- testis: 249 nTPM
- skeletal muscle: 228 nTPM
- heart muscle: 174 nTPM
- epididymis: 173 nTPM
- kidney: 170 nTPM
Single-cell type
- late primary spermatocytes: 720 nCPM
- early spermatids: 331 nCPM
- oocytes: 309 nCPM
- esophageal apical cells: 306 nCPM
- gastric progenitor cells: 290 nCPM
- early primary spermatocytes: 272 nCPM
Immune cell
- plasmacytoid DC: 132 nTPM
- intermediate monocyte: 126 nTPM
- eosinophil: 122 nTPM
- classical monocyte: 115 nTPM
- memory B-cell: 114 nTPM
- T-reg: 114 nTPM
Brain region
- basal ganglia: 39 nTPM
- pons: 20 nTPM
- midbrain: 19 nTPM
- cerebellum: 18 nTPM
- thalamus: 17 nTPM
- white matter: 15 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CSNK2B.
Disease | AllUniProt
Conditions CSNK2B is implicated in, by any mechanism.
- Poirier-Bienvenu neurodevelopmental syndrome (POBINDS) MIM:618732
Disease | GeneticClinVar
103 pathogenic / likely-pathogenic of 197 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Poirier-Bienvenu neurodevelopmental syndrome
- Inborn genetic diseases
- CSNK2B-related disorder
- CSNK2B-Related Neurodevelopmental Disorder
- Neurodevelopmental disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.38
- gnomAD pLI
- 0.92
- gnomAD missense Z
- 3.13
- DepMap mean gene effect
- -0.85
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adiponectin-activated signaling pathway
- endothelial tube morphogenesis
- negative regulation of blood vessel endothelial cell migration
- negative regulation of cell population proliferation
- negative regulation of proteasomal ubiquitin-dependent protein catabolic process
- negative regulation of viral life cycle
- positive regulation of activin receptor signaling pathway
- positive regulation of SMAD protein signal transduction
- protein-containing complex assembly
- signal transduction
- symbiont-mediated disruption of host cell PML body
- Wnt signaling pathway
Molecular functions
- chromatin binding
- identical protein binding
- metal ion binding
- protein domain specific binding
- protein kinase regulator activity
- protein serine/threonine kinase activity
- protein-macromolecule adaptor activity
- RNA polymerase II-specific DNA-binding transcription factor binding
- signaling receptor binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Casein kinase II, regulatory subunit
- Casein kinase II, regulatory subunit, N-terminal
- Casein kinase II subunit beta-like
- Casein kinase II regulatory subunit
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CSNK2B in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CSNK2B as an antibody target. Whether an autoantibody or antibody against CSNK2B could matter depends on whether native CSNK2B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CSNK2B is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CSNK2B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...